Real-time enrollment status for this neonatal encephalopathy clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:01 AM UTC
| NCT Number | NCT06098833 |
| Recruiting Status | Recruiting |
| Condition | Neonatal Encephalopathy |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pia Wintermark |
| Last Updated on CT.gov | September 17, 2026 (4 weeks ago) |
As of October 15, 2026: Clinical trial NCT06098833 is currently recruiting participants. This phase2 study for neonatal encephalopathy is actively seeking new participants at 1 location across the United States. The study is sponsored by Pia Wintermark. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06098833 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06098833 was last updated 4 weeks ago (September 17, 2026). HelloStudys verifies this status automatically.